Short answer · Medically reviewed summary · Last updated: 2023-07-13
Alveolar Capillary Dysplasia (ACD) is an extremely rare congenital disorder affecting the development of the lungs. It is characterized by abnormal development of the alveolar capillaries, which are tiny blood vessels essential for gas exchange in the lungs.
What is the prevalence of Alveolar Capillary Dysplasia?
Prevalence of Alveolar Capillary Dysplasia: how many people are affected worldwide, differences by sex and region, with sources.
Alveolar Capillary Dysplasia (ACD) is an extremely rare congenital disorder affecting the development of the lungs. It is characterized by abnormal development of the alveolar capillaries, which are tiny blood vessels essential for gas exchange in the lungs. ACD is typically diagnosed in newborns or infants and is associated with severe respiratory distress and pulmonary hypertension.
The prevalence of Alveolar Capillary Dysplasia is estimated to be around 1 in 50,000 to 1 in 100,000 live births. Due to its rarity, ACD is considered a challenging condition to diagnose accurately. The exact cause of ACD is still unknown, although some cases have been linked to genetic mutations. The prognosis for infants with ACD is generally poor, with most cases resulting in early death within the first few weeks of life.
Early recognition and diagnosis of ACD are crucial for appropriate management and potential lung transplantation. Genetic counseling may be recommended for families affected by ACD to understand the risk of recurrence in future pregnancies. Ongoing research and advancements in medical technology are essential to improve our understanding of this rare disorder and develop potential treatment options.
